IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis
Abstract Background Methotrexate (MTX) is the standard first-line therapy in rheumatoid arthritis (RA) with variable clinical efficacy that is difficult to predict. The glycosylation status of immunoglobulin G (IgG) is altered in RA and influenced by MTX treatment. We aimed to further investigate if...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2017-08-01
|
| Ráidu: | Arthritis Research & Therapy |
| Fáttát: | |
| Liŋkkat: | http://link.springer.com/article/10.1186/s13075-017-1389-7 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|